SMS PHARMACEUTICALS
Back to Balance Sheet
|
SMS PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹48 Cr | ₹43 Cr | ₹41 Cr | ₹40 Cr | ₹54 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SMS PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹48 Cr |
| Mar2024 | ₹43 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹40 Cr |
| Mar2021 | ₹54 Cr |
How is Deferred Tax Assets / Liabilities of SMS PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹48 Cr | 12.38 | |
| Mar2024 | ₹43 Cr | 4.34 | |
| Mar2023 | ₹41 Cr | 3.71 | |
| Mar2022 | ₹40 Cr | -26.56 | |
| Mar2021 | ₹54 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SMS PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SMS PHARMACEUTICALS | ₹3,838.0 Cr | 8.6% | 11.7% | 64.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,704.0 Cr | -0.3% | 3.4% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,684.0 Cr | -2.5% | -1.2% | -1.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,093.0 Cr | 2.4% | 5.2% | 47.2% | Stock Analytics | |
| CIPLA | ₹117,699.0 Cr | 2.2% | 4.8% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,792.0 Cr | 4.3% | 4.1% | 4.5% | Stock Analytics | |
SMS PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SMS PHARMACEUTICALS | 8.6% |
11.7% |
64.4% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses